Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer
Chinese Academy of Medical Sciences & Peking Union Medical College · Peking Union Medical College Hospital · +3 more institutions
Abstract
Abstract Despite the successful application of immune checkpoint therapy, no response or recurrence is typical in lung cancer. Cancer stem cells (CSCs) have been identified as a crucial player in immunotherapy-related resistance. Ferroptosis, a form of cell death driven by iron-dependent lipid peroxidation, is highly regulated by cellular metabolism remolding and has been shown to have synergistic effects when combined with immunotherapy. Metabolic adaption of CSCs drives tumor resistance, yet the mechanisms of their ferroptosis defense in tumor immune evasion remain elusive. Here, through metabolomics, transcriptomics, a lung epithelial-specific Cpt1a -knockout mouse model, and clinical analysis, we…
Citation impact
- FWCI
- 62.04
- Percentile
- 100%
- References
- 49
Authors
11- LMLei MaCorresponding
Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital
- CCChong Chen
Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital
- CZChunxing Zhao
Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital
- TLTong Li
National Health Research Institutes, Tianjin Medical University General Hospital
- LMLingyu Ma
Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital
Topics & keywords
- Cancer research
- Carnitine
- Biology
- Immune system
- Immunotherapy
- Immune checkpoint
- Lung cancer
- Immunology
- Good health and well-being